Summary of opinion: Frontpro (previously Afoxolaner Merial) Positive

Summary of opinion: Mhyosphere PCV ID, 06/11/2025 Positive

Withdrawn application: Dupixent, 18/02/2025

Personalised medicine in oncology

Cancer medicines

Release notes - production release version 1.7.2541 - 7 November 2025 - Veterinary Medicinal Products Regulation: Union Product Database

Clinical Trial Information System (CTIS) - Sponsor handbook

Human medicines European public assessment report (EPAR): Cubicin, daptomycin, Date of authorisation: 19/01/2006, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Zepatier, elbasvir,grazoprevir, Date of authorisation: 22/07/2016, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Zoledronic acid Mylan, zoledronic acid, Date of authorisation: 23/08/2012, Revision: 17, Status: Authorised